module 8 study tool

hemoglobinopathies

thalassemia

Hemoglobin diseases

sickle cell anemia

S-beta thalassemia

E

SC

D

C

O

Qualitative defect

quantitative defect

homozygous or heterozygous

It is gene mutation

most common

places it can occur

most common: africa

other places: mediterranean, middle east, india, nepal

chromosome 11 mutation that changed glu->valine

pathophysiology

net negative charge made

deoxyhemoglobin s molecules polymerize

creates the sickle cell shape

anemia

85-38% oxygen saturation

happens in hypoxic, acidotic, hypertonic microenvironment

clinical features

symptoms: hemolytic anemia, Vaso occlusion of microvasculature, infections, acute splenic sequetration

peripheral smear: poik, aniso, polychromasia

5-20% reticulocytes

variety of cells but diagnosis would be the sickle shaped cells

increased: bilirubin, uric acid, lactic dehydrogenase

decreased haptoglobin

diagnosing

Adults: screening solubility test

newborn

prenatal DNA analysis

Hgb electrophoresis

isoelectric focusing

high performance liquid chromatography

alkaline hemoglobin electrophoresis

can only do preventative measures for treatment

prophylactic penicillin

avoid dehydration

PRBC transfusion

pharmacological agents to increase hemoglobin F production

hematopoietic stem cell transplant

hemoglobin crystals (bar of gold)

mainly known in African people

decreased life span of RBC (30-55 days)

joint and abdominal pain

enlarged spleen

the trait is asymptomatic

no treatment

normochromic, normocytic anemia

increased target cells

2-3% reticulocytes

negative solubility test

Definitive Dx by electrophoresis, HPLC, and nucleic acid testing

morphology: microcytic, hypochromic, polychromasia, target cells

both chains are abnormal

creates beta s and beta c chains

no hemoglobin a

both chains are abnormal

codes for beta s and c chains

hemoglobin A is absent

"mild" sickle cell disease

sickling and Hgb C crystals are there

vaso occlusive crises

splenomegaly

normochromic/normocytic anemis

solubility test is positive

in the electrophoresis Hgb s and c move the same amount

F is normal

symptoms

electrophoresis

morphology: target cells

homozygous: mild hemolytic anemia and splenomegaly

heterozygous: asymptomatic

alkaline: moves with C, E, and A2

acidic: moves to A position

morphology: few target cells

symptoms: asymptomatic

electrophoresis

acidic: moves to A

alkaline: moves to a band at s and one at A2

symptoms: asymptomatic

electrophoresis: strong band in HgbC/A2 position

symptoms: splenomegaly

electophoresis: a band at s and one at A2

morphology: Microcytic, hypochromic, nucleated RBCs, Reticulocytes, target cells, polychromasia, & Sickle cells

mild- asymptomatic, severe-anemia, hepatosplenomegaly, infections, gallstones, bone deformities

mutation gets rid of globin chains

beta thalassemia

alpha thalassemis

major (Hgb Barts hydrops fetalis syndroms)

symptoms start at about 6 months

distorts the cell

symptoms: failure to thrive, enlarged spleen, bone fractures, anemia, jaundice, frequent transfusions, diabetes

peripheral smear has: microcytic, hypochromic anemia, nRBCs, precipitates stain with methyl violet stain

lab results

decreased MCV, MCH, MCHC

secondary leukopenia and thrombocytopenia

dark urine

elecrtophoresis

will show deficient beta chain production

in adult: 0% A, 90% F, less than 2.5% A2

treatment: hyper transfusion, iron chelating agents, splenectomy

if left untreated they will die by 20

can have hepatic and cardiac disturbances

Intermedia: it is not well defined but is asymptomatic

has moderate microcytic hypochromic anemia and shows target cells, basophilic stippling and nRBC's

minor

silent

found mainly in asian populations

Hgb H disease

halotype (--/--)

not compatible with life

severe anemia, microcytic, hypochromic, elevated reticulocytes, elevated nRBC's

dangerous for mom and fetus

halotype: (--/-alpha)

Barts produced at birth with y chain production

at 6 months changes to Hgb H

chronic hemolysis/ anemia, splenomegaly, 50% chance of skeletal changes, Hgb=8-10 g/dL, elevated retics, nrbcs, inclusions can be seen with brilliant cresyl blue

electrophoresis

adult: 40% hgb H

infant 25% bart hgb

1 unaffected alpha chain, one deleted

(--/alpha, alpha)

asymptomatic

you can find microcytic, hypochromic anemia, Hgb H inclusions

electrophoresis in newborns shoe 5-6% barts

can be masked by iron deficiency anemia

only 1/4 of the chain genes are missing

asymptomatic

can find borderline low MCV, slight microcytosis

genetic analysis is the only reliable diagnostic tool